Carboplatin Treatment Options in United Kingdom

A collection of 302 research studies where Carboplatin is the interventional treatment. These studies are located in the United Kingdom . Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.

Home

United Kingdom

All Treatments

Carboplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

NCT03715933

Recruiting

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody targeting the human death receptor 5 (DR5).

Gender:

ALL

Ages:

Between 12 years and 85 years

Trial Updated:

12/09/2024

Locations: HonorHealth Research Institute, Scottsdale, Arizona +33 locations

HonorHealth Research Institute, Scottsdale, Arizona

Precision NextGen Oncology and Research, Beverly Hills, California

City of Hope, Duarte, California

Valkyrie Clinical Trials, Los Angeles, California

University of California, San Diego (UCSD) - Moores Cancer Center, San Diego, California

University of California, San Francisco (UCSF), San Francisco, California

Sarcoma Oncology Center, Santa Monica, California

University of Colorado Hospital, Aurora, Colorado

Emory University - Winship Cancer Institute, Atlanta, Georgia

The University of Chicago, Chicago, Illinois

Center for Cancer Research at NCI, Bethesda, Maryland

University of Michigan, Ann Arbor, Michigan

START Midwest Michigan, PC, Grand Rapids, Michigan

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York

Cleveland Clinic, Cleveland, Ohio

Oregon Health & Science University, Portland, Oregon

Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia, Pennsylvania

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania

Vanderbilt University School of Medicine, Nashville, Tennessee

UT MD Anderson Cancer Center, Houston, Texas

NEXT Oncology, San Antonio, Texas

University of Virginia, Charlottesville, Virginia

NEXT Oncology - Virginia, Fairfax, Virginia

Centre Leon Berard, Lyon, Not set

Gustave Roussy, Villejuif Cedex, Not set

La Fondazione e l'Istituto di Candiolo, Candiolo, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Hospital Universitario Vall d'Hebron, Barcelona, Not set

Hospital de la Santa Creu i Sant Pau, Barcelona, Not set

Hospital Clinico San Carlos, Madrid, Not set

Great North Children's Hospital, London, Not set

University College London Hospital, London, Not set

The Royal Marsden NHS Foundation Trust, London, Not set

Royal Manchester Children's Hospital, Manchester, Not set

Conditions: Colorectal Adenocarcinoma, Ewing Sarcoma

Learn More ›

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

NCT03215706

Completed

The purpose of this study is to determine whether Nivolumab, Ipilimumab combined with chemotherapy is more effective than chemotherapy by itself when treating stage IV NSCLC as the first treatment given for the disease

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/06/2024

Locations: Memorial Health Systems, Colorado Springs, Colorado +115 locations

Memorial Health Systems, Colorado Springs, Colorado

Local Institution - 0044, Plainville, Connecticut

Local Institution - 0045, Jacksonville, Florida

Local Institution - 0029, Marietta, Georgia

Local Institution - 0091, Wichita, Kansas

Local Institution - 0004, Lexington, Kentucky

Local Institution - 0105, Detroit, Michigan

Local Institution - 0058, Johnson City, New York

Local Institution - 0098, Mineola, New York

Local Institution - 0095, Columbus, Ohio

Local Institution - 0006, Lancaster, Pennsylvania

Local Institution - 0047, Pittsburgh, Pennsylvania

Local Institution - 0093, Pittsburgh, Pennsylvania

Local Institution - 0094, Charleston, South Carolina

Southwest Regional Cancer Clinic, Saint George, Utah

Local Institution - 0099, Madison, Wisconsin

Local Institution - 0014, Ciudad Autónoma de Buenos Aires, Buenos Aires

Local Institution - 0028, Rio Cuarto, Cordoba

Local Institution - 0026, Viedma, Rio Negro

Local Institution - 0027, Rosario, Santa Fe

Local Institution - 0030, Cordoba, Not set

Local Institution - 0086, Gosford, New South Wales

Local Institution - 0040, Bedford Park, South Australia

Local Institution - 0089, Box Hill, Victoria

Local Institution - 0036, Heidelberg, Victoria

Local Institution - 0078, Murdoch, Western Australia

Local Institution - 0002, Gilly, Not set

Local Institution - 0033, Leuven, Not set

Local Institution - 0001, Roeselare, Not set

Local Institution - 0068, Natal, RIO Grande DO Norte

Local Institution - 0063, Ijui, Rio Grande Do Sul

Local Institution - 0067, Porto Alegre, Rio Grande Do Sul

Local Institution - 0069, Blumenau, Santa Catarina

Local Institution - 0064, Barretos, Sao Paulo

Local Institution - 0065, Sao Jose Do Rio Preto, Sao Paulo

Local Institution - 0066, Rio De Janeiro, Not set

Local Institution - 0070, São Paulo, Not set

Local Institution - 0090, Montreal, Quebec

Local Institution - 0083, Montreal, Quebec

Local Institution - 0082, Montreal, Quebec

Local Institution - 0080, Rimouski, Quebec

Local Institution - 0084, Santiago, Metropolitana

Local Institution - 0059, Santiago, Región Metropolitana De Santiago

Local Institution - 0079, Vina Del Mar, Valparaiso

Local Institution - 0139, Beijing, BEI

Local Institution - 0146, Haikou, Hainan

Local Institution - 0148, Zhengzhou, Henan

Local Institution - 0120, Zhengzhou, Henan

Local Institution - 0144, Changsha, Hunan

Local Institution - 0106, Changchun, Jilin

Local Institution - 0108, Xi'an City, Shan3xi

Local Institution - 0110, Hangzhou, Zhejiang

Local Institution - 0111, Zhejiang, Zhejiang

Local Institution - 0113, Beijing, Not set

Local Institution - 0112, Shanghai, Not set

Local Institution - 0010, Bron, Rhone Alpes

Local Institution - 0009, Lyon Cedex08, Rhône-Alpes

Local Institution - 0013, Caen, Not set

Local Institution - 0071, Lille Cedex, Not set

Local Institution - 0012, Montpellier, Not set

Local Institution - 0035, Nantes, Not set

Local Institution - 0011, Paris Cedex 20, Not set

Local Institution - 0097, Saint-Brieuc, Not set

Local Institution - 0073, Berlin, Not set

Local Institution - 0016, Gauting, Not set

Local Institution - 0072, Grosshansdorf, Not set

Local Institution - 0019, Hemer, Not set

Local Institution - 0017, Immenhausen, Not set

Local Institution - 0074, Magdeburg, Not set

Local Institution - 0015, Muenchen, Not set

Local Institution - 0018, Stuttgart, Not set

Local Institution - 0021, Dublin, Not set

Local Institution - 0020, Limerick, Not set

Local Institution - 0042, Lucca, Not set

Local Institution - 0041, Milano, Not set

Local Institution - 0043, Napoli, Not set

Local Institution - 0101, Fukushima-shi, Fukushima

Local Institution - 0118, Maebashi-shi, Gunma

Local Institution - 0128, Ota-shi, Gunma

Local Institution - 0138, Hiroshima-shi, Hiroshima

Local Institution - 0137, Hiroshima-shi, Hiroshima

Local Institution - 0127, Sapporo-shi, Hokkaido

Local Institution - 0131, Akashi-shi, Hyogo

Local Institution - 0119, Himeji-shi, Hyogo

Local Institution - 0104, Kobe-shi, Hyogo

Local Institution - 0115, Kanazawa-shi, Ishikawa

Local Institution - 0100, Shiwa-gun, Iwate

Local Institution - 0129, Yokohama-shi, Kanagawa

Local Institution - 0114, Yokohama-Shi, Kanagawa

Local Institution - 0134, Yokohama-shi, Kanagawa

Local Institution - 0116, Niigata-shi, Niigata

Local Institution - 0136, Okayama-shi, Okayama

Local Institution - 0135, Habikino-shi, Osaka

Local Institution - 0103, Osaka-Sayama, Osaka

Local Institution - 0102, Kitaadachi-gun, Saitama

Local Institution - 0132, Ube-shi, Yamaguchi

Local Institution - 0130, Osaka, Not set

Local Institution - 0077, La Paz, BAJA Californa SUR

Local Institution - 0061, Guadalajara, Jalisco

Local Institution - 0075, Veracruz, Veracruz, Not set

Local Institution - 0087, Bydgoszcz, Not set

Local Institution - 0022, Bytom, Not set

Local Institution - 0085, Gdańsk, Not set

Local Institution - 0034, Bucharest, Not set

Local Institution - 0031, Cluj Napoca, Not set

Local Institution - 0032, Craiova, Not set

Local Institution - 0024, Moscow, Not set

Local Institution - 0025, St.petersburg, Not set

Local Institution - 0054, A Coruña, Not set

Local Institution - 0053, Barcelona, Not set

Local Institution - 0052, Madrid, Not set

Local Institution - 0055, Malaga, Not set

Local Institution - 0056, Valencia, Not set

Local Institution - 0050, Guildford, Not set

Local Institution - 0049, London, Not set

Local Institution - 0048, Tauton, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

NCT01566240

Active Not Recruiting

Chemoradiation has been the standard treatment for advanced cervical cancer for a decade, but one third of women still die from a failure to control systemic disease. In a recent multicentre phase II trial of 46 women the investigators found that, 68% of women had tumours that responded to weekly induction chemotherapy prior to chemoradiation. The induction chemotherapy had acceptable toxicity and did not compromise the standard chemoradiation treatment. In addition, the overall survival and pro... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

12/04/2024

Locations: Instituto do Câncer do Estado de São Paulo, São Paulo, Not set +34 locations

Instituto do Câncer do Estado de São Paulo, São Paulo, Not set

Chittaranjan National Cancer Institute (CNCI), Kolkata, Not set

Saroj Gupta Cancer Centre and Research Institute, Kolkata, Not set

Istituto Europeo di Oncologia, Milan, Lombardy

Instituto Nacional de Cancerologia (INCAN), Mexico City, Not set

North Devon District Hospital, Barnstaple, Devon

University College London Hospital, London, Greater London

Weston Park Hospital, Sheffield, South Yorkshire

Belfast City Hospital, Belfast, Not set

Pilgrim Hospital, Boston, Not set

Royal Sussex County Hospital, Brighton, Not set

Velindre Cancer Centre, Cardiff, Not set

Cheltenham General Hospital, Cheltenham, Not set

Royal Derby Hospital, Derby, Not set

Royal Devon and Exeter NHS Foundation Trust, Exeter, Not set

Beatson WOSCC, Glasgow, Not set

Gloucester Royal Hospital, Gloucester, Not set

Grantham and District Hospital, Grantham, Not set

Castle Hill Hospital, Hull, Not set

Leicester Royal Infirmary, Leicester, Not set

Lincoln County Hospital, Lincoln, Not set

Guy's and St Thomas' NHS Foundation Trust, London, Not set

Imperial College Healthcare NHS Trust, London, Not set

St Bart's Hospital, London, Not set

The Christie NHS Foundation Trust, Manchester, Not set

James Cook University Hospital, Middlesbrough, Not set

Northampton General Hospital, Northampton, Not set

Norfolk and Norwich University Hospital, Norwich, Not set

Nottingham University Hospitals NHS Trust, Nottingham, Not set

Derriford Hospital, Plymouth, Not set

Southampton General Hospital, Southampton, Not set

Royal Stoke University Hospital, Stoke-On-Trent, Not set

Royal Cornwall Hospital, Truro, Not set

The Clatterbridge Cancer Centre, Wirral, Not set

New Cross Hospital, Wolverhampton, Not set

Conditions: Cervical Cancer

Learn More ›

Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05221645

Active Not Recruiting

This is an open-label, multicentre, randomised phase II trial in relapsed or refractory diffuse large B-cell lymphoma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/04/2024

Locations: Oxford Cancer & Haematology Centre, The Churchill Hospital, Headington, Oxford +1 locations

Conditions: Diffuse Large B Cell Lymphoma

Learn More ›

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features

NCT05255653

Recruiting

The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. Eligible patients will be assigned to one of the four RAINBO trials based on the molecular profile of their cancer: * p53 abnormal endometrial cancer patients to the p53abn-RED trial * mismatch repair deficient endometrial cancer patients to the MMRd-GREEN trial * no specific molecular profile endometrial cancer patients to NSMP-ORANGE trial * POLE mutant endometrial... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/26/2024

Locations: The POLEmut-BLUE trial: Princess Margaret Cancer Centre, University of Toronto, Toronto, Not set +13 locations

Conditions: Endometrial Cancer

Learn More ›

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

NCT03981796

Active Not Recruiting

This is a 2 part study. Part 1 is to evaluate the efficacy and safety of dostarlimab plus carboplatin-paclitaxel followed by dostarlimab versus placebo plus carboplatin-paclitaxel followed by placebo; and Part 2 is to evaluate the efficacy and safety of dostarlimab plus carboplatin-paclitaxel followed by dostarlimab plus niraparib versus placebo plus carboplatin-paclitaxel followed by placebo in participants with recurrent or primary advanced (Stage III or IV) endometrial cancer.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/26/2024

Locations: GSK Investigational Site, Phoenix, Arizona +168 locations

GSK Investigational Site, Phoenix, Arizona

GSK Investigational Site, Scottsdale, Arizona

GSK Investigational Site, Tempe, Arizona

GSK Investigational Site, Tucson, Arizona

GSK Investigational Site, Newport Beach, California

GSK Investigational Site, Palo Alto, California

GSK Investigational Site, Deerfield Beach, Florida

GSK Investigational Site, Jacksonville, Florida

GSK Investigational Site, Miami, Florida

GSK Investigational Site, Orlando, Florida

GSK Investigational Site, Augusta, Georgia

GSK Investigational Site, Savannah, Georgia

GSK Investigational Site, Hinsdale, Illinois

GSK Investigational Site, Zion, Illinois

GSK Investigational Site, Fort Wayne, Indiana

GSK Investigational Site, Indianapolis, Indiana

GSK Investigational Site, Iowa City, Iowa

GSK Investigational Site, Lexington, Kentucky

GSK Investigational Site, Covington, Louisiana

GSK Investigational Site, New Orleans, Louisiana

GSK Investigational Site, Shreveport, Louisiana

GSK Investigational Site, Boston, Massachusetts

GSK Investigational Site, Springfield, Massachusetts

GSK Investigational Site, Detroit, Michigan

GSK Investigational Site, Saint Louis, Missouri

GSK Investigational Site, Lebanon, New Hampshire

GSK Investigational Site, Albuquerque, New Mexico

GSK Investigational Site, Rio Rancho, New Mexico

GSK Investigational Site, Albany, New York

GSK Investigational Site, Bronx, New York

GSK Investigational Site, Mineola, New York

GSK Investigational Site, New York, New York

GSK Investigational Site, Charlotte, North Carolina

GSK Investigational Site, Durham, North Carolina

GSK Investigational Site, Kernersville, North Carolina

GSK Investigational Site, Mount Airy, North Carolina

GSK Investigational Site, Winston-Salem, North Carolina

GSK Investigational Site, Cincinnati, Ohio

GSK Investigational Site, Cleveland, Ohio

GSK Investigational Site, Columbus, Ohio

GSK Investigational Site, Hilliard, Ohio

GSK Investigational Site, Tulsa, Oklahoma

GSK Investigational Site, Philadelphia, Pennsylvania

GSK Investigational Site, Pittsburgh, Pennsylvania

GSK Investigational Site, Wexford, Pennsylvania

GSK Investigational Site, Willow Grove, Pennsylvania

GSK Investigational Site, Providence, Rhode Island

GSK Investigational Site, Knoxville, Tennessee

GSK Investigational Site, Austin, Texas

GSK Investigational Site, Dallas, Texas

GSK Investigational Site, Fort Worth, Texas

GSK Investigational Site, Charlottesville, Virginia

GSK Investigational Site, Roanoke, Virginia

GSK Investigational Site, Seattle, Washington

GSK Investigational Site, Grodno, Not set

GSK Investigational Site, Minsk, Not set

GSK Investigational Site, Aalst, Not set

GSK Investigational Site, Leuven, Not set

GSK Investigational Site, LiEge, Not set

GSK Investigational Site, Calgary, Alberta

GSK Investigational Site, Winnipeg, Manitoba

GSK Investigational Site, Ottawa, Ontario

GSK Investigational Site, Sault Ste Marie, Ontario

GSK Investigational Site, Toronto, Ontario

GSK Investigational Site, Montreal, Quebec

GSK Investigational Site, QuEbec, Not set

GSK Investigational Site, Brno, Not set

GSK Investigational Site, Praha 2, Not set

GSK Investigational Site, Aalborg, Not set

GSK Investigational Site, Copenhagen, Not set

GSK Investigational Site, Herlev, Not set

GSK Investigational Site, Odense C, Not set

GSK Investigational Site, Roskilde, Not set

GSK Investigational Site, Kuopio, Not set

GSK Investigational Site, Tampere, Not set

GSK Investigational Site, Turku, Not set

GSK Investigational Site, Amberg, Not set

GSK Investigational Site, Bad Homburg, Not set

GSK Investigational Site, Dessau, Not set

GSK Investigational Site, Dresden, Not set

GSK Investigational Site, Essen, Not set

GSK Investigational Site, Frankfurt, Not set

GSK Investigational Site, Giessen, Not set

GSK Investigational Site, Hamburg, Not set

GSK Investigational Site, Hannover, Not set

GSK Investigational Site, Jena, Not set

GSK Investigational Site, Karlsruhe, Not set

GSK Investigational Site, Kiel, Not set

GSK Investigational Site, Koeln, Not set

GSK Investigational Site, Luebeck, Not set

GSK Investigational Site, Mainz, Not set

GSK Investigational Site, Muenchen, Not set

GSK Investigational Site, Offenbach, Not set

GSK Investigational Site, Ravensburg, Not set

GSK Investigational Site, Rosenheim, Not set

GSK Investigational Site, Tuebingen, Not set

GSK Investigational Site, Ulm, Not set

GSK Investigational Site, Wiesbaden, Not set

GSK Investigational Site, Marousi, Not set

GSK Investigational Site, Thessaloniki, Not set

GSK Investigational Site, Budapest, Not set

GSK Investigational Site, Debrecen, Not set

GSK Investigational Site, Ashkelon, Not set

GSK Investigational Site, Beer-Sheva, Not set

GSK Investigational Site, Haifa, Not set

GSK Investigational Site, Jerusalem, Not set

GSK Investigational Site, Petach Tikva, Not set

GSK Investigational Site, Rehovot, Not set

GSK Investigational Site, Tel Aviv, Not set

GSK Investigational Site, Biella, Not set

GSK Investigational Site, Candiolo, Not set

GSK Investigational Site, Carpi MO, Not set

GSK Investigational Site, Lecce, Not set

GSK Investigational Site, Milano, Not set

GSK Investigational Site, Naples, Not set

GSK Investigational Site, Rome, Not set

GSK Investigational Site, Sassuolo, Not set

GSK Investigational Site, Trento, Not set

GSK Investigational Site, Udine, Not set

GSK Investigational Site, Amsterdam, Not set

GSK Investigational Site, Eindhoven, Not set

GSK Investigational Site, Enschede, Not set

GSK Investigational Site, Groningen, Not set

GSK Investigational Site, Maastricht, Not set

GSK Investigational Site, Rotterdam, Not set

GSK Investigational Site, Bergen, Not set

GSK Investigational Site, Oslo, Not set

GSK Investigational Site, Stavanger, Not set

GSK Investigational Site, Troms, Not set

GSK Investigational Site, Trondheim, Not set

GSK Investigational Site, Bialystok, Not set

GSK Investigational Site, Gdynia, Not set

GSK Investigational Site, Lodz, Not set

GSK Investigational Site, Olsztyn, Not set

GSK Investigational Site, Poznan, Not set

GSK Investigational Site, Szczecin, Not set

GSK Investigational Site, Warszawa, Not set

GSK Investigational Site, Barcelona, Not set

GSK Investigational Site, Madrid, Not set

GSK Investigational Site, MAlaga, Not set

GSK Investigational Site, Murcia, Not set

GSK Investigational Site, San SebastiAn, Not set

GSK Investigational Site, Valencia, Not set

GSK Investigational Site, Linkoping, Not set

GSK Investigational Site, Lund, Not set

GSK Investigational Site, Stockholm, Not set

GSK Investigational Site, Uppsala, Not set

GSK Investigational Site, Adapazari, Not set

GSK Investigational Site, Ankara, Not set

GSK Investigational Site, Istanbul, Not set

GSK Investigational Site, Chernihiv, Not set

GSK Investigational Site, Kharkiv, Not set

GSK Investigational Site, Brighton, Not set

GSK Investigational Site, Cambridge, Not set

GSK Investigational Site, London, Not set

GSK Investigational Site, Truro, Not set

Conditions: Neoplasms

Learn More ›

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

NCT05173987

Active Not Recruiting

The purpose of this study is to assess the safety and efficacy of treatment with pembrolizumab (MK-3475) compared to a combination of carboplatin and paclitaxel in women with mismatch repair deficient (dMMR) advanced or recurrent endometrial carcinoma who have not previously been treated with prior systemic chemotherapy. The primary study hypotheses are that pembrolizumab is superior to the combination of carboplatin and paclitaxel with respect to Progression Free Survival (PFS) per Response Ev... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/19/2024

Locations: HonorHealth-USOR HonorHealth ( Site 8000), Phoenix, Arizona +194 locations

HonorHealth-USOR HonorHealth ( Site 8000), Phoenix, Arizona

Moores Cancer Center ( Site 0037), La Jolla, California

Kaiser Permanente Riverside Medical Center ( Site 0045), Riverside, California

Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0013), New Haven, Connecticut

Mount Sinai Cancer Center ( Site 0018), Miami Beach, Florida

Sarasota Memorial Hospital ( Site 0005), Sarasota, Florida

Northside Hospital ( Site 0017), Atlanta, Georgia

Southeastern Regional Medical Center ( Site 0046), Newnan, Georgia

Midwestern Regional Medical Center,Inc. DBA CTCA, Chicago ( Site 0003), Zion, Illinois

St. Vincent Hospital and Health Care Center, Inc ( Site 0006), Indianapolis, Indiana

Baptist Health Lexington ( Site 0042), Lexington, Kentucky

Maryland Oncology Hematology, P.A.-USOR Maryland Oncology Hematology, P.A. ( Site 8002), Rockville, Maryland

University of Massachusetts Medical School-Division of Gynecologic Oncology ( Site 0008), Worcester, Massachusetts

Karmanos Cancer Institute ( Site 0029), Detroit, Michigan

St. Dominic's Hospital ( Site 0024), Jackson, Mississippi

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0026), Hackensack, New Jersey

The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0023), New York, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0016), New York, New York

Icahn School of Medicine at Mount Sinai ( Site 0052), New York, New York

Memorial Sloan Kettering Cancer Center ( Site 0009), New York, New York

FirstHealth Clinical Trials ( Site 0050), Pinehurst, North Carolina

Sanford Medical Center ( Site 0054), Bismarck, North Dakota

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0055), Fargo, North Dakota

University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0039), Cincinnati, Ohio

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus, Ohio

Providence Portland Medical Center ( Site 0031), Portland, Oregon

Sidney Kimmel Cancer Center - Jefferson Health ( Site 0053), Philadelphia, Pennsylvania

University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0034), Pittsburgh, Pennsylvania

AHN West Penn Hospital ( Site 0011), Pittsburgh, Pennsylvania

Asplundh Cancer Pavilion ( Site 0014), Willow Grove, Pennsylvania

Sanford Cancer Center-Gynecologic Oncology ( Site 0002), Sioux Falls, South Dakota

Texas Oncology - Austin-USOR Texas Oncology - Austin ( Site 8003), Austin, Texas

Texas Oncology - Dallas-USOR Texas Oncology - Dallas (Sammons) ( Site 8005), Dallas, Texas

Texas Oncology - Tyler-USOR Texas Oncology - Northeast Texas ( Site 8004), Tyler, Texas

VCU Health Adult Outpatient Pavillion ( Site 0022), Richmond, Virginia

Northern Cancer Institute ( Site 0206), St Leonards, New South Wales

Westmead Hospital-Department of Gynaecological Oncology ( Site 0201), Westmead, New South Wales

Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, Brisbane, Queensland

Monash Health ( Site 0202), Clayton, Victoria

Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0207), Melbourne, Victoria

Epworth Freemasons ( Site 0203), Melbourne, Victoria

St. John of God Subiaco Hospital-Oncology Clinical Trials Unit ( Site 0204), Subiaco, Western Australia

Institut Jules Bordet-Medicine Oncology ( Site 0321), Bruxelles, Bruxelles-Capitale, Region De

Grand Hôpital de Charleroi-Oncology & Hematology ( Site 0323), Charleroi, Hainaut

Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman ( Site 0320), Liège, Liege

Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 3005), Natal, Rio Grande Do Norte

ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 3001), São Paulo, Sao Paulo

A. C. Camargo Cancer Center-CAPEC ( Site 3003), Sao Paulo, Not set

Cross Cancer Institute ( Site 0513), Edmonton, Alberta

BC Cancer Kelowna ( Site 0517), Kelowna, British Columbia

BC Cancer Vancouver-Clinical Trials Unit ( Site 0518), Vancouver, British Columbia

Sunnybrook Health Sciences - Odette Cancer Centre ( Site 0509), Toronto, Ontario

Princess Margaret Cancer Centre ( Site 0510), Toronto, Ontario

Jewish General Hospital ( Site 0504), Montreal, Quebec

Centre Hospitalier de l'Université de Montréal ( Site 0519), Montréal, Quebec

McGill University Health Centre ( Site 0505), Montréal, Quebec

Saskatoon Cancer Center-Clinical Research Department ( Site 0520), Saskatoon, Saskatchewan

FALP-UIDO ( Site 0602), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 0604), Santiago, Region M. De Santiago

Bradfordhill-Clinical Area ( Site 0603), Santiago, Region M. De Santiago

Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 0730), Hefei, Anhui

Beijing Obstetric and Gynecology Hospital ( Site 0740), Beijing, Beijing

Peking University First Hospital ( Site 0723), Beijing, Beijing

Beijing Cancer hospital ( Site 0715), Beijing, Beijing

Southwest Hospital of Third Military Medical University ( Site 0719), Chongqing, Chongqing

2nd Affiliated Hospital Chongqing Medical Universi ( Site 0745), Chongqing, Chongqing

Fuling Central Hospital ( Site 0733), Fulingqu, Chongqing

Fujian Provincial Cancer Hospital ( Site 0720), Fuzhou, Fujian

SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 0710), Guangzhou, Guangdong

Cancer Hospital of Shantou University Medical College ( Site 0732), Shantou, Guangdong

Affiliated Hospital of Guangdong Medical College ( Site 0731), Zhanjiang, Guangdong

Guangxi Medical University Affiliated Tumor Hospital-Gynecological oncology ( Site 0704), Nanning, Guangxi

Hainan General Hospital ( Site 0703), Haikou, Hainan

Harbin Medical University Cancer Hospital ( Site 0711), Harbin, Heilongjiang

Henan Cancer Hospital ( Site 0713), Zhengzhou, Henan

Wuhan Union Hospital-Medical Oncology ( Site 0716), Wuhan, Hubei

Xiangya Hospital Central South University-Gynecology ( Site 0708), Changsha, Hunan

Hunan Cancer Hospital ( Site 0709), Changsha, Hunan

Jiangsu Province Hospital-Oncology Department ( Site 0707), Nanjing, Jiangsu

The First Affiliated Hospital of Nanchang University ( Site 0729), Nanchang, Jiangxi

The First Hospital of Jilin University ( Site 0705), Changchun, Jilin

Shaanxi Provincial Cancer Hospital ( Site 0714), XI An, Shaanxi

Binzhou Medical University Hospital-Oncology department ( Site 0735), Binzhou, Shandong

Obstetrics & Gynecology Hospital of Fudan University ( Site 0702), Shanghai, Shanghai

Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 0717), Shanghai, Shanghai

West China Second University Hospital Sichuan University ( Site 0701), Chengdu, Sichuan

Tianjin Medical University Cancer Institute and Hospital ( Site 0706), Tianjin, Tianjin

Yunnan Province Cancer Hospital-Gynecology Department ( Site 0721), Kunming, Yunnan

The Affiliated Women's Hospital of Zhejiang University-Obstetrics and Gynecology ( Site 0726), Hangzhou, Zhejiang

Zhejiang Cancer Hospital-Oncology ( Site 0700), Hangzhou, Zhejiang

The First Affiliated Hospital of Wenzhou Medical University-Gynecology ( Site 0725), Wenzhou, Zhejiang

Fakultní nemocnice Brno Bohunice-Gynekologicko-porodnicka klinika ( Site 0404), Brno, Brno-mesto

Fakultni nemocnice Ostrava-Gynekologicko-porodnicka klinika ( Site 0403), Ostrava, Moravskoslezsky Kraj

Nemocnice AGEL Novy Jicin a.s.-Oddeleni radioterapie a onkologie ( Site 0406), Nový Jiín, Novy Jicin

Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0402), Olomouc, Olomoucky Kraj

Vseobecna fakultni nemocnice v Praze-Gynekologicko-porodnicka klinika 1.LF a VFN ( Site 0405), Praha, Praha 2

Fakultni nemocnice Bulovka-Gynekologicko-porodnicka klinika ( Site 0401), Praha, Praha 8

Nemocnice Tomase Bati ve Zline-Onkologické oddělení ( Site 0407), Zlín, Zlinsky Kraj

Fakultni nemocnice Kralovske Vinohrady-Gynekologicko-porodnická klinika ( Site 0408), Praha 10, Not set

Rigshospitalet ( Site 0903), Copenhagen, Hovedstaden

Herlev and Gentofte Hospital ( Site 0902), Copenhagen, Hovedstaden

Aalborg Universitetshospital, Syd ( Site 0905), Aalborg, Nordjylland

Roskilde Sygehus-Oncology department ( Site 0904), Roskilde, Sjaelland

Tampereen yliopistollinen sairaala-Gynecology and Obstetrics ( Site 1001), Tampere, Pirkanmaa

Kuopion Yliopistollinen Sairaala ( Site 1002), Kuopio, Pohjois-Savo

Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus) ( Site 1003), Helsinki, Uusimaa

Universitaetsklinikum Ulm ( Site 1106), Ulm, Baden-Wurttemberg

Universitätsklinikum Bonn-Gynaecological oncology ( Site 1105), Bonn, Nordrhein-Westfalen

Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur, Dresden, Sachsen

Charité Campus Virchow-Klinikum ( Site 1103), Berlin, Not set

Országos Onkológiai Intézet-Ngyógyászat ( Site 1201), Budapest, Not set

Bon Secours Cork Hospital ( Site 1305), Cork, Not set

St. James's Hospital-Cancer clinical trials office ( Site 1301), Dublin, Not set

Soroka Medical Center ( Site 1403), Be'er Sheva, Not set

Rambam Health Care Campus-Gyneco-oncology unit ( Site 1402), Haifa, Not set

Edith Wolfson Medical Center-Obstetrics & Gynecology ( Site 1405), Holon, Not set

Shaare Zedek Medical Center ( Site 1404), Jerusalem, Not set

Sheba Medical Center ( Site 1401), Ramat Gan, Not set

Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Sperimentale Uro-Genitale ( Site 1, Napoli, Campania

IRCCS - AOU di Bologna-SSD Oncologia medica Addarii ( Site 1503), Bologna, Emilia-Romagna

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Oncologia Medica ( Site 1513), Meldola, Emilia-Romagna

Fondazione Policlinico Universitario Agostino Gemelli-Ginecologia Oncologica ( Site 1502), Roma, Lazio

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Chirurgia Ginecologica ( Site 150, Milan, Lombardia

Ospedale Mauriziano-SCDU ONCOLOGIA MEDICA ( Site 1514), Torino, Piemonte

Istituto Nazionale Tumori Regina Elena-Oncologia Medica 1 ( Site 1504), Rome, Roma

Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 1509), Firenze, Toscana

AULSS8 Berica-Ospedale S.Bortolo-ONCOLOGIA CLINICA ( Site 1510), Vicenza, Veneto

Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 1506), Milano, Not set

National Cancer Center Hospital East ( Site 1604), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 1611), Matsuyama, Ehime

Ehime University Hospital ( Site 1614), Toon, Ehime

Kurume University Hospital ( Site 1612), Kurume, Fukuoka

Gunma Prefectural Cancer Center-Gynecology ( Site 1603), Ota, Gunma

Hokkaido University Hospital ( Site 1601), Sapporo, Hokkaido

Tsukuba University Hospital ( Site 1618), Tsukuba, Ibaraki

Iwate Medical University Hospital ( Site 1602), Shiwa-gun Yahaba-cho, Iwate

Niigata University Medical & Dental Hospital ( Site 1613), Chuo-ku, Niigata, Niigata

Saitama Medical University International Medical Center ( Site 1605), Hidaka-shi, Saitama

Shizuoka Cancer Center ( Site 1609), Nagaizumi-cho,Sunto-gun, Shizuoka

National Cancer Center Hospital ( Site 1607), Chuo-ku, Tokyo

Japanese Foundation for Cancer Research ( Site 1616), Koto, Tokyo

The Jikei University Hospital ( Site 1615), Minato-ku, Tokyo

Keio university hospital ( Site 1606), Shinjyuku-ku, Tokyo

National Hospital Organization Kyushu Cancer Center ( Site 1608), Fukuoka, Not set

Osaka International Cancer Institute ( Site 1617), Osaka, Not set

Seoul National University Hospital ( Site 2302), Seoul, Not set

Severance Hospital, Yonsei University Health System-Gynecologic cancer center ( Site 2301), Seoul, Not set

Asan Medical Center-Division of Gynecologic Oncology, Dept. of Obstetrics & Gynecology ( Site 2303), Seoul, Not set

Gangnam Severance Hospital ( Site 2304), Seoul, Not set

Radboudumc-Medical Oncology ( Site 1703), Nijmegen, Gelderland

Maastricht UMC+ ( Site 1709), Maastricht, Limburg

Catharina Ziekenhuis-Oncology ( Site 1704), Eindhoven, Noord-Brabant

Amsterdam UMC, locatie AMC ( Site 1706), Amsterdam, Noord-Holland

Leids Universitair Medisch Centrum-Medical Oncology ( Site 1702), Leiden, Zuid-Holland

Erasmus Medisch Centrum-Medical Oncology ( Site 1701), Rotterdam, Zuid-Holland

University Medical Center Groningen ( Site 1707), Groningen, Not set

Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 1705), Utrecht, Not set

Auckland City Hospital-Cancer & Blood Research ( Site 1801), Auckland, Not set

Oslo universitetssykehus, Radiumhospitalet ( Site 1901), Oslo, Not set

Centrum Onkologii Ziemi Lubelskiej ( Site 2006), Lublin, Lubelskie

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2007), Siedlce, Mazowieckie

Szpital Kliniczny im. Księżnej Anny Mazowieckiej ( Site 2009), Warsaw, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit, Warszawa, Mazowieckie

Bialostockie Centrum Onkologii-Oddzial Onkologii Ginekologicznej ( Site 2003), Bialystok, Podlaskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach-III Klinika Radioterapii i Chemioterapii ( Site 20, Gliwice, Slaskie

Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej ( Site 2010), Kielce, Swietokrzyskie

Szpital Kliniczny im. Heliodora Święcickiego Uniwersytetu Me-Oddzial Ginekologii Onkologicznej ( Sit, Poznan, Wielkopolskie

Moscow City Oncology Hospital #62 ( Site 2204), Krasnogorsk, Moskovskaya Oblast

Yaroslavl Regional Cancer Hospital-Oncology ( Site 2202), Yaroslavl, Yaroslavskaya Oblast

Institut Català d'Oncologia - L'Hospitalet-Medical Oncology ( Site 2406), Hospitalet, Barcelona

CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 2405), A Coruña, La Coruna

Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 2402), Madrid, Madrid, Comunidad De

COMPLEJO HOSPITALARIO DE NAVARRA ( Site 2407), Pamplona, Navarra

Fundación Instituto Valenciano de Oncología-Oncologico ( Site 2404), Valencia, Valenciana, Comunitat

Hospital Universitari Vall d'Hebron ( Site 2403), Barcelona, Not set

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO ( Site 2401), Sevilla, Not set

Skånes Universitetssjukhus Lund-Department of Hematology ( Site 2504), Lund, Skane Lan

Karolinska Universitetssjukhuset Solna ( Site 2502), Solna, Stockholms Lan

Norrlands universitetssjukhus-Cancercentrum ( Site 2503), Umeå, Vasterbottens Lan

Taichung Veterans General Hospital ( Site 2602), Taichung, Not set

NATIONAL CHENG-KUNG UNI. HOSP. ( Site 2604), Tainan, Not set

National Taiwan University Hospital ( Site 2603), Taipei, Not set

Mackay Memorial Hospital ( Site 2601), Taipei, Not set

Taipei Veterans General Hospital ( Site 2605), Taipei, Not set

Istanbul Universitesi Cerrahpasa ( Site 2702), Fatih, Istanbul

Hacettepe Universite Hastaneleri-oncology hospital ( Site 2704), Ankara, Not set

Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 2706), Ankara, Not set

Akdeniz Universitesi Hastanesi ( Site 2701), Antalya, Not set

Istanbul University Capa Campus-department of obstetrics and gynaecology ( Site 2705), Istanbul, Not set

T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma, Istanbul, Not set

St Bartholomew's Hospital ( Site 2804), London, England

The Christie ( Site 2807), Manchester, England

The Beatson West of Scotland Cancer Centre ( Site 2805), Glasgow, Glasgow City

ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 2806), London, London, City Of

Hammersmith Hospital-Medical Oncology ( Site 2808), London, London, City Of

Conditions: Endometrial Neoplasms

Learn More ›

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

NCT02477826

Completed

The purpose of this study is to show that Nivolumab, or Nivolumab plus Ipilimumab, or Nivolumab plus Platinum-Doublet Chemotherapy improves progression free survival and/or overall survival compared with chemotherapy in patients with advanced lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/16/2024

Locations: Southern Cancer Center, Inc., Mobile, Alabama +289 locations

Southern Cancer Center, Inc., Mobile, Alabama

Local Institution - 0017, San Francisco, California

Local Institution - 0021, New Haven, Connecticut

Local Institution - 0001, Atlanta, Georgia

Local Institution - 0013, Marietta, Georgia

Local Institution - 0004, Lexington, Kentucky

Local Institution - 0115, Saint Louis, Missouri

Local Institution - 0005, Buffalo, New York

Local Institution - 0019, New York, New York

Local Institution - 0014, Cleveland, Ohio

Local Institution - 0009, Columbus, Ohio

Local Institution - 0007, Allentown, Pennsylvania

Local Institution - 0075, Langhorne, Pennsylvania

Local Institution - 0299, Philadelphia, Pennsylvania

Local Institution - 0012, Philadelphia, Pennsylvania

Local Institution - 0015, Sayre, Pennsylvania

Local Institution - 0008, Charleston, South Carolina

Local Institution - 0080, Greenville, South Carolina

Local Institution - 0010, Greenville, South Carolina

Local Institution - 0020, Nashville, Tennessee

Local Institution - 0306, Dallas, Texas

Local Institution - 0003, Dallas, Texas

Local Institution - 0102, Houston, Texas

Local Institution - 0011, Salt Lake City, Utah

Local Institution - 0074, Kennewick, Washington

Local Institution - 0170, Berazategui, Buenos Aires

Local Institution - 0171, Capital Federal, Buenos Aires

Local Institution - 0172, Ciudad Autonoma De Buenos Aire, Buenos Aires

Local Institution - 0176, Ciudad de Buenos Aires, Buenos Aires

Local Institution - 0296, Mar Del Plata, Buenos Aires

Local Institution - 0177, Viedma, RIO Negro

Local Institution - 0130, San Miguel de Tucuman, Tucuman

Local Institution - 0268, Cordoba, Not set

Local Institution - 0272, Córdoba, Not set

Local Institution - 0297, Córdoba, Not set

Local Institution - 0182, Garran, Australian Capital Territory

Local Institution - 0301, Blacktown, New South Wales

Local Institution - 0300, Gosford, New South Wales

Local Institution - 0045, Brisbane, Queensland

Local Institution - 0046, Elizabeth Vale, South Australia

Local Institution - 0043, Clayton, Victoria

Local Institution - 0042, Fitzroy, Victoria

Local Institution - 0180, Perth, Western Australia

Local Institution - 0040, Murdoch, Not set

Local Institution - 0183, North Tamworth, Not set

Local Institution - 0241, Graz, Not set

Local Institution - 0240, Vienna, Not set

Local Institution - 0239, Wels, Not set

Local Institution - 0121, Roeselare, West-Vlaanderen

Local Institution - 0030, Edegem, Not set

Local Institution - 0031, Gent, Not set

Local Institution - 0034, Gilly, Not set

Local Institution - 0117, Hasselt, Not set

Local Institution - 0033, Sint Niklaas, Not set

Local Institution - 0125, Salvador, Bahia

Local Institution - 0124, Ijui, RIO Grande DO SUL

Local Institution - 0123, Porto Alegre, Rio Grande Do Sul

Local Institution - 0127, Barretos, Sao Paulo

Local Institution - 0129, Rio De Janeiro, Not set

Local Institution - 0144, Sao Paulo, Not set

Local Institution - 0126, Sao Paulo, Not set

Local Institution - 0128, Sao Paulo, Not set

Local Institution - 0103, Edmonton, Alberta

Local Institution - 0290, St. John's, Newfoundland and Labrador

Local Institution - 0104, London, Ontario

Local Institution - 0122, Montreal, Quebec

Local Institution - 0106, Quebec City, Quebec

Local Institution - 0107, Rimouski, Quebec

Local Institution - 0291, Sherbrooke, Quebec

Local Institution - 0292, Trois-Rivieres, Quebec

Local Institution - 0302, Quebec, Not set

Local Institution - 0173, Santiago, Metropolitana

Local Institution - 0131, Santiago, Región Metropolitana De Santiago

Local Institution - 0174, Vina Del Mar, Valparaiso

Local Institution - 0380, Hefei, Anhui

Local Institution - 0313, Beijing, Beijing

Local Institution - 0315, Beijing, Beijing

Local Institution - 0316, Beijing, Beijing

Local Institution - 0314, Beijing, Beijing

Local Institution - 0365, Chongqing, Chongqing

Local Institution - 0364, Chongqing, Chongqing

Local Institution - 0378, Chongqing, Chongqing

Local Institution - 0322, Guangzhou, Guangdong

Local Institution - 0372, Guangzhou, Guangdong

Local Institution - 0319, Guanzhou, Guangdong

Local Institution - 0323, Haikou, Hainan

Local Institution - 0325, Haerbin, Heilongjiang

Local Institution - 0324, Zhengzhou, Henan

Local Institution - 0379, Zhengzhou, Henan

Local Institution - 0375, Wuhan, Hubei

Local Institution - 0362, Changsha, Hunan

Local Institution - 0347, Nanchang, Jiangxi

Local Institution - 0329, Changchun, Jilin

Local Institution - 0361, Changchun, Jilin

Local Institution - 0359, Shenyang, Liaoning

Local Institution - 0371, Xi'an, Shaanxi

Local Institution - 0333, Xi'an, Shan3xi

Local Institution - 0360, Qingdao, Shandong

Local Institution - 0334, Shanghai, Shanghai

Local Institution - 0376, Chengdu, Sichuan

Local Institution - 0373, Tianjin, Tianjin

Local Institution - 0340, Urumqi, Xinjiang

Local Institution - 0343, Hangzhou, Zhejiang

Local Institution - 0370, Hangzhou, Zhejiang

Local Institution - 0342, Hangzhou, Zhejiang

Local Institution - 0328, Changsha, Not set

Local Institution - 0341, Hangzhou, Not set

Local Institution - 0345, Kunming, Not set

Local Institution - 0336, Shanghai, Not set

Local Institution - 0337, Shanghai, Not set

Local Institution - 0374, Shantou, Not set

Local Institution - 0273, Pereira, Risaralda

Local Institution - 0237, Bogota, Not set

Local Institution - 0238, Bogota, Not set

Local Institution - 0282, Medellin, Not set

Local Institution - 0112, Hradec Kralove, Not set

Local Institution - 0113, Olomouc, Not set

Local Institution - 0111, Praha 4, Not set

Local Institution - 0232, Pribram, Not set

Local Institution - 0270, Oulu, Not set

Local Institution - 0271, Turku, Not set

Local Institution - 0222, Bron, Rhône

Local Institution - 0216, ANGERS Cedex 2, Not set

Local Institution - 0229, Besançon Cedex, Not set

Local Institution - 0283, Caen, Not set

Local Institution - 0218, Creteil, Not set

Local Institution - 0228, Limoges, Not set

Local Institution - 0215, Marseille Cedex 20, Not set

Local Institution - 0230, Paris, Not set

Local Institution - 0227, Pessac, Not set

Local Institution - 0223, Rennes, Not set

Local Institution - 0225, Rouen, Not set

Local Institution - 0221, Saint Priest En Jarez, Not set

Local Institution - 0217, Saint-herblain Cedex, Not set

Local Institution - 0224, Strasbourg, Not set

Local Institution - 0226, Toulon, Not set

Local Institution - 0231, Magdeburg, Sachsen-Anhalt

Local Institution - 0213, Bad Berka, Not set

Local Institution - 0208, Berlin, Not set

Local Institution - 0205, Essen, Not set

Local Institution - 0210, Frankfurt, Not set

Local Institution - 0211, Gera, Not set

Local Institution - 0203, Grosshansdorf, Not set

Local Institution - 0209, Halle, Not set

Local Institution - 0202, Heidelberg, Not set

Local Institution - 0214, Hemer, Not set

Local Institution - 0206, Immenstadt, Not set

Local Institution - 0204, Muenchen, Not set

Local Institution - 0201, Stuttgart, Not set

Local Institution - 0212, Wiesbaden, Not set

Local Institution - 0094, Athens, Attikí

Local Institution - 0095, Heraklion, Not set

Local Institution - 0190, Neo Faliro, Not set

Local Institution - 0101, Thessaloniki, Not set

Local Institution - 0025, Budapest, Not set

Local Institution - 0024, Budapest, Not set

Local Institution - 0026, Matrahaza, Not set

Local Institution - 0054, Dublin 8, Dublin

Local Institution - 0053, Beaumont, Not set

Local Institution - 0055, Galway, Not set

Local Institution - 0100, Limerick, Not set

Local Institution - 0187, Jerusalem, Not set

Local Institution - 0186, Kfar-saba, Not set

Local Institution - 0185, Petach Tikva, Not set

Local Institution - 0184, Tel-hashomer, Not set

Local Institution - 0188, Zerifin, Not set

Local Institution - 0083, Milan, Lombardia

Azienda Ospedaliera Moscati, Avellino, Not set

Local Institution - 0179, Bergamo, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set

Local Institution - 0084, Livorno, Not set

Policlinico G. Martino, Messina, Not set

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Not set

Istituto Nazionale Tumori Fondazione Pascale, Napoli, Not set

Local Institution - 0087, Perugia, Not set

Ospedale Santa Maria delle Croci, Ravenna, Not set

Ifo-Istituto Regina Elena, Roma, Not set

Local Institution - 0089, Roma, Not set

Local Institution - 0085, Terni, Not set

Local Institution - 0153, Nagoya-shi, Aichi

Local Institution - 0152, Nagoya, Aichi

Local Institution - 0148, Kashiwa-shi, Chiba

Local Institution - 0159, Matsuyama, Ehime

Local Institution - 0160, Fukuoka-shi, Fukuoka

Local Institution - 0259, Kurume-shi, Fukuoka

Local Institution - 0255, Ota-shi, Gunma

Local Institution - 0258, Hiroshima-shi, Hiroshima

Local Institution - 0163, Sapporo-shi, Hokkaido

Local Institution - 0253, Sapporo-shi, Hokkaido

Local Institution - 0252, Akashi-shi, Hyogo

Local Institution - 0156, Kobe-shi, Hyogo

Local Institution - 0146, Kanazawa-shi, Ishikawa

Local Institution - 0161, Yokohama-shi, Kanagawa

Local Institution - 0150, Yokohama-Shi, Kanagawa

Local Institution - 0275, Natori-shi, Miyagi

Local Institution - 0254, Sendai-shi, Miyagi

Local Institution - 0145, Sendai-shi, Miyagi

Local Institution - 0164, Niigata-shi, Niigata

Local Institution - 0158, Kurashiki-shi, Okayama

Local Institution - 0155, Hirakata-shi, Osaka

Local Institution - 0154, Osaka-shi, Osaka

Local Institution - 0251, Osakasayama-shi, Osaka

Local Institution - 0257, Takatsuki-shi, Osaka

Local Institution - 0353, Hidaka-shi, Saitama

Local Institution - 0256, Kitaadachi-gun, Saitama

Local Institution - 0151, Sunto-gun, Shizuoka

Local Institution - 0147, Chuo-ku, Tokyo

Local Institution - 0149, Koto-ku, Tokyo

Local Institution - 0278, Shinjuku-ku, Tokyo

Local Institution - 0157, Wakayama-shi, Wakayama

Local Institution - 0354, Ube-shi, Yamaguchi

Local Institution - 0260, Chiba, Not set

Local Institution - 0165, Okayama, Not set

Local Institution - 0162, Tokyo, Not set

Local Institution - 0136, Seongnam-si, Kyǒnggi-do

Local Institution - 0249, Cheongju-si, Not set

Local Institution - 0133, Gangnam-gu, Not set

Local Institution - 0132, Seoul, Not set

Local Institution - 0135, Seoul, Not set

Local Institution - 0287, Beirut, Not set

Local Institution - 0286, Beirut, Not set

Local Institution - 0196, Df, Distrito Federal

Local Institution - 0193, Mexico, Distrito Federal

Local Institution - 0198, Cuautitlan, Estado DE Mexico

Local Institution - 0197, Guadalajara, Jalisco

Local Institution - 0191, Zapopan, Jalisco

Local Institution - 0267, Morelia, Michoacan

Local Institution - 0277, Monterrey, Nuevo Leon

Local Institution - 0303, Merida, Yucatán

Local Institution - 0192, Chihuahua, Not set

Local Institution - 0195, San Luis Potosi, Not set

Local Institution - 0236, San Luis Potosi, Not set

Local Institution - 0194, Toluca, Not set

Local Institution - 0036, Amsterdam, Not set

Local Institution - 0189, Amsterdam, Not set

Local Institution - 0169, Breda, Not set

Local Institution - 0037, Rotterdam, Not set

Local Institution - 0039, Veldhoven, Not set

Local Institution - 0262, Lima, Not set

Local Institution - 0263, Lima, Not set

Local Institution - 0350, Lima, Not set

Local Institution - 0261, Lima, Not set

Local Institution - 0351, Lima, Not set

Local Institution - 0060, Bydgoszcz, Not set

Local Institution - 0058, Gdansk, Not set

Local Institution - 0063, Gdynia, Not set

Local Institution - 0072, Gliwice, Not set

Local Institution - 0057, Lodz, Not set

Local Institution - 0059, Warszawa, Not set

Local Institution - 0070, Wroclaw, Not set

Local Institution - 0167, Craiova, Not set

Local Institution - 0250, Floresti, Not set

Local Institution - 0166, Romania, Not set

Local Institution - 0284, Sector 2, Not set

Local Institution - 0137, Chelyabinsk, Not set

Local Institution - 0142, Kazan, Not set

Local Institution - 0022, Moscow, Not set

Local Institution - 0049, Saint-Petersburg, Not set

Local Institution - 0028, St. Petersburg, Not set

Local Institution - 0027, St. Petersburg, Not set

Local Institution - 0143, Ufa, Not set

Local Institution - 0264, Pretoria, Gauteng

Local Institution - 0234, Sandton, Gauteng

Local Institution - 0233, Saxonwold, Johannesburg, Gauteng

Local Institution - 0305, Vereeniging, Not set

Local Institution - 0064, Majadahonda, Madrid

Local Institution - 0066, Barcelona, Not set

Local Institution - 0067, Barcelona, Not set

Local Institution - 0065, Madrid, Not set

Local Institution - 0069, Sevilla, Not set

Local Institution - 0068, Valencia, Not set

Local Institution - 0243, Basel, Not set

Local Institution - 0246, Chur, Not set

Local Institution - 0244, Lausanne, Not set

Local Institution - 0245, Winterthur, Not set

Local Institution - 0139, Taichung, Not set

Local Institution - 0138, Taipei, Not set

Local Institution - 0140, Taipei, Not set

Local Institution - 0310, Taipei, Not set

Local Institution - 0141, Taoyuan city, Not set

Local Institution - 0266, Middlesborough, Cleveland

Local Institution - 0098, London, Greater London

Local Institution - 0099, Southampton, Hampshire

Local Institution - 0118, Leicester, Leicestershire

Local Institution - 0265, Birmingham, Not set

Local Institution - 0051, Cambridgeshire, Not set

Local Institution - 0109, Edinburgh, Not set

Local Institution - 0097, London, Not set

Local Institution - 0050, London, Not set

Local Institution - 0119, Surrey, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

NCT04191135

Active Not Recruiting

The purpose of this study is to compare the efficacy of olaparib (MK-7339) plus pembrolizumab (MK-3475) with chemotherapy plus pembrolizumab after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The primary hypotheses are: 1. Olaparib plus pembrolizumab is superior to chemotherapy plus pembrolizumab with respect to progression-free survival (PFS). 2. Olaparib plus pembrolizumab is superior to chemotherapy plus pembrolizumab with respect to over... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/11/2024

Locations: Pacific Cancer Care ( Site 0142), Monterey, California +121 locations

Pacific Cancer Care ( Site 0142), Monterey, California

UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138), San Francisco, California

John Wayne Cancer Institute ( Site 0111), Santa Monica, California

St. Joseph Heritage Healthcare ( Site 0104), Santa Rosa, California

University of Miami Sylvester CC ( Site 0146), Miami, Florida

Georgia Cancer Center at Augusta University ( Site 0129), Augusta, Georgia

University of Chicago ( Site 0159), Chicago, Illinois

Massachusetts General Hospital ( Site 0155), Boston, Massachusetts

Henry Ford Health System ( Site 0103), Detroit, Michigan

Virginia Piper Cancer Institute ( Site 0157), Minneapolis, Minnesota

Memorial Sloan Kettering Cancer Center- Monmouth ( Site 0161), Middletown, New Jersey

MSKCC-Bergen ( Site 0162), Montvale, New Jersey

Memorial Sloan-Kettering Cancer Center at Commack ( Site 0160), Commack, New York

Memorial Sloan-Kettering Cancer Center ( Site 0156), New York, New York

Mercy Clinic Oncology and Hematology ( Site 0110), Oklahoma City, Oklahoma

The Center For Cancer And Blood Disorders ( Site 0151), Fort Worth, Texas

Texas Oncology-New Braunfels ( Site 0168), New Braunfels, Texas

Texas Oncology-San Antonio Northeast ( Site 0165), San Antonio, Texas

Texas Oncology-San Antonio Medical Center ( Site 0158), San Antonio, Texas

Texas Oncology - San Antonio Stone Oak ( Site 0166), San Antonio, Texas

Renovatio Clinical ( Site 0117), The Woodlands, Texas

Virginia Oncology Associates ( Site 0163), Newport News, Virginia

Virginia Oncology Associates ( Site 0153), Norfolk, Virginia

Virginia Oncology Associates ( Site 0164), Virginia Beach, Virginia

YVMH dba Virginia Mason Memorial/North Star Lodge Cancer Center ( Site 0128), Yakima, Washington

Princess Margaret Cancer Centre ( Site 0005), Toronto, Ontario

CSSS de Laval- Hopital de la Cite de la Sante ( Site 0011), Laval, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0003), Montreal, Quebec

Jewish General Hospital ( Site 0010), Montreal, Quebec

McGill University Health Centre ( Site 0002), Montreal, Quebec

Centro Investigación del Cáncer James Lind ( Site 0510), Temuco, Araucania

IC La Serena Research ( Site 0511), La Serena, Coquimbo

Fundacion Arturo Lopez Perez ( Site 0500), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile ( Site 0501), Santiago, Region M. De Santiago

Oncocentro ( Site 0502), Vina del Mar, Valparaiso

Fundacion Colombiana de Cancerologia Clinica Vida ( Site 0601), Medellin, Antioquia

Clinica de la Costa Ltda. ( Site 0600), Barranquilla, Atlantico

Organizacion Clinica Bonnadona-Prevenir S.A.S. ( Site 0609), Barranquilla, Atlantico

Oncomedica S.A. ( Site 0606), Monteria, Cordoba

Fundacion Valle del Lili ( Site 0602), Cali, Valle Del Cauca

Hemato Oncologos S.A. ( Site 0603), Cali, Valle Del Cauca

Centre Francois Baclesse ( Site 1012), Caen, Calvados

CHU-Jean Minjoz ( Site 1013), Besancon, Doubs

Institut Claudius Regaud IUCT Oncopole ( Site 1001), Toulouse, Haute-Garonne

Centre de Cancerologie du Grand Montpellier ( Site 1009), Montpellier, Languedoc-Roussillon

CHR-METZ-THIONVILLE - Hopital de Mercy ( Site 1007), Metz, Moselle

Centre Jean Perrin ( Site 1003), Clermont-Ferrand Cedex 01, Puy-de-Dome

Centre Leon Berard ( Site 1018), Lyon, Rhone

Centre Henri Becquerel ( Site 1020), Rouen, Seine-Maritime

CHU Amiens Hopital Sud ( Site 1023), Amiens, Somme

Institut Gustave Roussy ( Site 1010), Villejuif, Val-de-Marne

Institut Sainte Catherine ( Site 1026), Avignon, Vaucluse

Hôpital Saint-Louis ( Site 1025), Paris, Not set

Universitaetsklinikum Mannheim GmbH ( Site 1213), Mannheim, Baden-Wurttemberg

Universitaetsklinikum Erlangen ( Site 1201), Erlangen, Bayern

Klinik und Poliklinik fuer Frauenheilkunde und Geburtshilfe ( Site 1200), Muenchen, Bayern

Hochwaldkrankenhaus Bad Nauheim ( Site 1211), Bad Nauheim, Hessen

Sana Klinikum Offenbach Klinik fuer Gynakologie und Geburtshilfe ( Site 1206), Offenbach am Main, Hessen

Gynaekologisch-onkologische Praxis Hannover ( Site 1207), Hannover, Niedersachsen

Gynaekologisches Zentrum-Schwerpunkt Gyn. Onkologie ( Site 1205), Bonn, Nordrhein-Westfalen

Universitaetsklinikum AoeR Duesseldorf ( Site 1210), Duesseldorf, Nordrhein-Westfalen

Kliniken Essen-Mitte ( Site 1215), Essen, Nordrhein-Westfalen

Frauenklinik St. Louise ( Site 1216), Paderborn, Nordrhein-Westfalen

Universitaetsklinikum Carl Gustav Carus ( Site 1203), Dresden, Sachsen

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1608), Kecskemét, Bacs-Kiskun

Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 1607), Pecs, Baranya

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1601), Szolnok, Jasz-Nagykun-Szolnok

Zala Megyei Szent Rafael Korhaz ( Site 1605), Zalaegerszeg, Zala

Orszagos Onkologiai Intezet ( Site 1602), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont ( Site 1600), Debrecen, Not set

Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1604), Kaposvar, Not set

Cork University Hospital ( Site 0902), Cork, Not set

St Vincents University Hospital ( Site 0900), Dublin, Not set

Aichi Cancer Center Hospital ( Site 2202), Nagoya, Aichi

Hyogo College of Medicine Hospital ( Site 2203), Nishinomiya, Hyogo

Fukushima Medical University Hospital ( Site 2201), Fukushima, Not set

Hiroshima City Hiroshima Citizens Hospital ( Site 2204), Hiroshima, Not set

National Hospital Organization - Osaka National Hospital - Institute For Clinical Research (Site 2200), Osaka, Not set

National Cancer Center ( Site 2406), Goyang-si, Kyonggi-do

Seoul National University Bundang Hospital ( Site 2409), Seongnam-si, Kyonggi-do

Ajou University Hospital ( Site 2407), Suwon-si, Kyonggi-do

Kyungpook National University Chilgok Hospital ( Site 2402), Daegu, Taegu-Kwangyokshi

Gachon University Gil Medical Center ( Site 2408), Incheon, Not set

Seoul National University Hospital ( Site 2403), Seoul, Not set

Severance Hospital Yonsei University Health System ( Site 2401), Seoul, Not set

Asan Medical Center ( Site 2404), Seoul, Not set

Samsung Medical Center ( Site 2405), Seoul, Not set

Regionalny Szpital Specjalistyczny Latawiec ( Site 1917), Swidnica, Dolnoslaskie

Pratia MCM Krakow ( Site 1919), Krakow, Malopolskie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (Site 1908), Warszawa, Mazowieckie

Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 1913), Gdynia, Pomorskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1912), Gliwice, Slaskie

Pleszewskie Centrum Medyczne w Pleszewie Sp. z o.o. ( Site 1909), Pleszew, Wielkopolskie

Hospital Universitario Reina Sofia ( Site 0705), Cordoba, Andalucia

Hospital General Arnau de Vilanova de Valencia ( Site 0706), Valencia, Valenciana, Comunitat

Instituto Oncologico Baselga.Hospital Quiron. ( Site 0707), Barcelona, Not set

Hospital Universitari Vall d Hebron ( Site 0701), Barcelona, Not set

Hospital Clinic I Provincial de Barcelona ( Site 0702), Barcelona, Not set

Clinica Universitaria Navarra - Madrid ( Site 0700), Madrid, Not set

Kaohsiung Chang Gung Memorial Hospital ( Site 2304), Kaohsiung, Not set

National Cheng Kung University Hospital ( Site 2303), Tainan, Not set

MacKay Memorial Hospital ( Site 2301), Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center ( Site 2300), Taipei, Not set

China Medical University Hospital ( Site 2302), Taipei, Not set

Chernihiv Medical Center of Modern Oncology ( Site 1520), Chernihiv, Chernihivska Oblast

Dnipropetrovsk City Multidiscipline Clinical Hosp. 4 of DRC ( Site 1502), Dnipro, Dnipropetrovska Oblast

CI Krivorizhskiy oncology dispensery ( Site 1504), Kryviy Rih, Dnipropetrovska Oblast

MI Precarpathian Clinical Oncology Center ( Site 1506), Ivano-Frankivsk, Ivano-Frankivska Oblast

Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 1508), Kharkiv, Kharkivska Oblast

Communal non profit enterprise Regional Clinical Oncology Center ( Site 1512), Kharkiv, Kharkivska Oblast

SI-Zaytsev institute of general and urgent surgery-NAMS ( Site 1518), Kharkiv, Kharkivska Oblast

Medical Centre Consilium Medical ( Site 1514), Kyiv, Kyivska Oblast

Medical center of the Limited Liability Company Yulis ( Site 1517), Zaporizhzhia, Zaporizka Oblast

Medical Centre LLC Oncolife ( Site 1510), Zaporizhzhya, Zaporizka Oblast

Zhytomyr Regional Oncology Center ( Site 1515), Zhytomyr, Zhytomyrska Oblast

Medical Center Verum ( Site 1501), Kyiv, Not set

Raigmore Hospital ( Site 0915), Inverness, Highland

Blackpool Victoria Hospital ( Site 0921), Blackpool, Lancashire

North West Cancer Centre ( Site 0922), Londonderry, London, City Of

Barts Health NHS Trust ( Site 0912), London, London, City Of

Musgrove Park Hospital ( Site 0918), Taunton, Somerset

The Christie NHS Foundation Trust ( Site 0914), Manchester, Not set

Conditions: Triple Negative Breast Neoplasms

Learn More ›

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

NCT03371017

Completed

This study will evaluate the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative breast cancer (TNBC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/07/2024

Locations: Florida Cancer Specialists - Fort Myers (Broadway), Fort Myers, Florida +135 locations

Florida Cancer Specialists - Fort Myers (Broadway), Fort Myers, Florida

Florida Cancer Specialists & Research Institute, Saint Petersburg, Florida

The Valley Hospital, Paramus, New Jersey

Magee-Woman's Hospital; UPMC Pinnacle Cancer Center, Harrisburg, Pennsylvania

Magee-Woman's Hospital, Pittsburgh, Pennsylvania

SCRI Oncology Partners, Nashville, Tennessee

Inova Schar Cancer Institute, Falls Church, Virginia

Fundación CENIT para la Investigación en Neurociencias, Buenos Aires, Not set

Instituto de Oncología de Rosario, Rosario, Not set

Hospital Provincial del Centenario, Rosario, Not set

University Clinical Center of the Republic of Srpska, Banja Luka, Not set

Clinical center University of Sarajevo, Sarajevo, Not set

Oncocentro Serviços Medicos E Hospitalares Ltda, Fortaleza, CE

Hospital Araujo Jorge; Departamento de Ginecologia E Mama, Goiania, GO

Hospital do Cancer de Pernambuco - HCP, Recife, PE

Hospital Sao Vicente de Paulo, Passo Fundo, RS

Hospital Nossa Senhora da Conceicao, Porto Alegre, RS

Centro de Oncologia de Santa Catarina LTDA, Chapeco, SC

Instituto de Pesquisa Grupo NotreDame Intermedica, Sao Paulo, SP

Hospital Perola Byington, Sao Paulo, SP

Núcleo de Pesquisa São Camilo; ONCOLOGIA CLINICA / QUIMIOTERAPIA, Sao Paulo, SP

Patagonia Research, Puerto Montt, Not set

Bradford Hill Centro de Investigaciones Clinicas, Recoleta, Not set

Fundacion Arturo Lopez Perez, Santiago, Not set

Clinica Vespucio, Santiago, Not set

James Lind Centro de Investigación Del Cáncer, Temuco, Not set

ONCOCENTRO APYS; Oncología, Vina Del Mar, Not set

Cancer Hospital , Chinese Academy of Medical, Beijing City, Not set

Peking University People's Hospital, Beijing, Not set

Beijing Cancer Hospital, Beijing, Not set

the First Affiliated Hospital of Bengbu Medical College, Bengbu City, Not set

Jilin Cancer Hospital, Changchun, Not set

The First Affiliated Hospital, Chongqing Medical University, Chongqing, Not set

Fujian Medical University Union Hospital, Fuzhou City, Not set

Sun Yat-sen Memorial Hospital, Guangzhou, Not set

Sir Run Run Shaw Hospital Zhejiang University, Hangzhou City, Not set

Harbin Medical University Cancer Hospital, Harbin, Not set

Shandong Cancer Hospital, Jinan, Not set

The First Affiliated Hospital Of Jinzhou Medical University, Jinzhou City, Not set

Jiangsu Province Hospital, Nanjing, Not set

The Affiliated Hospital of Medical College Qingdao University, Qingdao, Not set

Fudan University Shanghai Cancer Center; Medical Oncology, Shanghai City, Not set

Hebei Medical University Fourth Hospital;(Tumor Hospital of Hebei Province), Shijiazhuang, Not set

Shanxi Province Cancer Hospital, Taiyuan City, Not set

Tianjin Cancer Hospital, Tianjin, Not set

The First Affiliated Hospital of The Fourth Military Medical University (Xijing Hospital), Xi'an, Not set

Zhejiang Cancer Hospital, Zhejiang, Not set

Hospital Hermanos Ameijeiras, La Habana, Not set

Instituto Nacional de Oncología y Radiología (INOR), La Habana, Not set

Helsinki University Central Hospital; Dept of Oncology, Helsinki, Not set

Tampere University Hospital; Dept of Oncology, Tampere, Not set

Centre Georges-François Lecler; Ctr de Lutte Contre le Canc, Dijon, Not set

Centre Leon Berard; Oncologie Genetique, Lyon, Not set

Institut Paoli-Calmettes; Oncologie Medicale 1, Marseille Cedex 09, Not set

Centre Régional de Lutte Contre Le Cancer Val D'aurelle Paul Lamarque, Montpellier, Not set

Centre Eugene Marquis; Service d'oncologie, Rennes, Not set

INSTITUT CURIE_SITE PARIS - Service d'Oncologie Médicale., St Cloud, Not set

Centre Alexis Vautrin; Oncologie Medicale, Vandoeuvre-les-nancy, Not set

IGR, Villejuif, Not set

Universitätsklinikum "Carl Gustav Carus"; Frauenheilkunde und Geburtshilfe, Dresden, Not set

Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum, Essen, Not set

Varisano Klinikum Frankfurt Höchst GmbH, Frankfurt, Not set

Universitätsklinikum Halle (Saale); Universitätsklinik Und Poliklinik Für Gynäkologie, Halle, Not set

Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, Hannover, Not set

Nationales Centrum für Tumorerkrankungen (NCT) ; Gyn. Onk. Frauenklinik; Uniklinikum Heidelberg, Heidelberg, Not set

Medizinisches Zentrum für Hämatologie und Onkologie, München, Not set

Szent Margit Hospital, Budapest, Not set

Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly, Budapest, Not set

Budapesti Uzsoki Utcai Kórház, Budapest, Not set

Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz;Sugarterapias Klinikai Onkologiai Intez, Miskolc, Not set

Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet, Pécs, Not set

Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Napoli, Campania

Azienda Ospedaliero Universitaria San Martino, Genova, Liguria

Ospedale San Raffaele S.r.l., Milano, Lombardia

Irccs Istituto Europeo Di Oncologia (IEO); Ricerca Di Senologia Medica, Milano, Lombardia

Ospedale San Gerardo, Monza, Lombardia

Fondazione Del Piemonte Per L'oncologia Ircc Di Candiolo; Dipartimento Oncologico, Candiolo, Piemonte

Ospedale Antonio Perrino; Oncologia Medica, Brindisi, Puglia

Azienda Ospedaliero-Universitaria Careggi; SOD Radioterapia, Firenze, Toscana

IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Seconda, Padova, Veneto

Kazakh Scientific Research Institution Of Oncology and Radiology, Almaty, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital, Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Centro Medico Dalinde, Cdmx, Mexico CITY (federal District)

CENEIT Oncologicos; DENTRO DE CONDOMINIO SAN FRANCISCO, Mexico City, Not set

Instituto Nacional de Cancerologia; Oncology, Mexico City, Not set

Clinical Center of Montenegro; Clinic for Oncology and Radiotherapy, Podgorica, Not set

Centre Hospitalier Universitaire Hassan II, FES, Not set

Centre Hospitalier Universitaire Mohamed VI; Oncologie-Hématologie, Marrakech, Not set

Clinique specialise Menara; Oncology Medical, Marrakech, Not set

Institut National D'oncologie Sidi Med Benabdellah, Rabat, Not set

The Panama Clinic, Panama, Not set

Instituto Nacional de Enfermedades Neoplasicas, Lima, Not set

?wi?tokrzyskie Centrum Onkologii; Dzia? Chemioterapii, Kielce, Not set

Narodowy Inst.Onkologii im.Sklodowskiej-Curie Panstw.Inst.Bad; Klinika Nowtw.Piersi i Chir.Rekonstr, Warszawa, Not set

Hospital de Santa Maria; Servico de Oncologia Medica, Lisboa, Not set

Centro Hospitalar do Porto ? Hospital de Santo António; Oncologia, Porto, Not set

Moscow City Oncology Hospital #62, Moscovskaya Oblast, Moskovskaja Oblast

Moscow Clinical Scientific Center, Moscow, Moskovskaja Oblast

FSBI "National Medical Research Center of Oncology N.N. Blokhin?, Moscow, Moskovskaja Oblast

City Clinical Oncology Dispensary, SPb SBIH CCOD, Saint-Petersburg, Sankt Petersburg

FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov", Saint-Petersburg, Sankt Petersburg

Private Healthcare Institution Clinical Hospital RZhD Medicine, St. Petersburg, Sankt Petersburg

Institute of Oncology and Radiology of Serbia, Belgrade, Not set

University Hospital Medical Center Bezanijska kosa, Belgrade, Not set

Clinical Centre Nis, Clinic for Oncology, Nis, Not set

Oncology Institute of Vojvodina, Sremska Kamenica, Not set

National Cancer Centre; Medical Oncology, Singapore, Not set

Wits Clinical Research; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Not set

Medical Oncology Centre of Rosebank; Oncology, Johannesburg, Not set

Private Oncology Centre, Pretoria, Not set

Hospital de Cruces; Servicio de Oncologia, Bilbao, Vizcaya

Hospital Universitari Vall d'Hebron; Oncology, Barcelona, Not set

Hospital General Universitario Gregorio Marañon; Servicio de Oncologia, Madrid, Not set

Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, Not set

Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia, Malaga, Not set

Hospital Clínico Universitario de Valencia; Servicio de Oncología, Valencia, Not set

Hacettepe University Medical Faculty; Department of Internal Medicine, Ankara, Not set

Ankara Oncology Hospital; Medical Oncology Department, Ankara, Not set

Ege University Medical Faculty; Medical Oncology Department, Bornova, ?zm?r, Not set

Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi, Edirne, Not set

Medipol University Medical Faculty; Oncology Department, Istanbul, Not set

Marmara University Pendik Training and Research Hospital; Medikal Onkoloji, Istanbul, Not set

Necmettin Erbakan University Meram Medical Faculty ; Internal Diseases, Konya, Not set

Velindre Cancer Centre; Oncology Dept, Cardiff, Not set

University Hospital Coventry, Coventry, Not set

Western General Hospital; Edinburgh Cancer Center, Edinburgh, Not set

Royal Lancaster Infirmary, Morecambe Bay Hospitals Nhs Trust, Lancaster, Not set

Barts, London, Not set

Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, Not set

Christie Hospital NHS Trust, Manchester, Not set

Mount Vernon Cancer Centre, Northwood, Not set

Royal Stoke University Hospital, Stoke-on-Trent, Not set

Conditions: Triple Negative Breast Neoplasms

Learn More ›

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

NCT03515837

Completed

The purpose of this study is to evaluate the efficacy and safety of pemetrexed plus platinum chemotherapy (carboplatin or cisplatin) with or without pembrolizumab (MK-3475; KEYTRUDA®) in the treatment of adults with the following types of tyrosine kinase inhibitor (TKI)-resistant, epidermal growth factor receptor (EGFR)-mutated, metastatic non-squamous non-small cell lung cancer (NSCLC) tumors: 1) TKI-failures (including osimertinib \[TAGRISSO®\] failure) with T790M-negative mutation tumors, 2)... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

11/05/2024

Locations: Cedars-Sinai Medical Center ( Site 0070), Los Angeles, California +157 locations

Cedars-Sinai Medical Center ( Site 0070), Los Angeles, California

Pacific Cancer Care ( Site 0058), Monterey, California

UC Irvine Medical Center/Chao Family Comprehensive Cancer Center ( Site 0092), Orange, California

St. Joseph Heritage Healthcare ( Site 0003), Santa Rosa, California

North Shore University Health System ( Site 0030), Evanston, Illinois

Siouxland Regioinal Cancer Center dba June E. Nylen Cancer Center ( Site 0065), Sioux City, Iowa

Southdale Cancer Care, University of Minnesota Medical Center- Edina ( Site 0048), Edina, Minnesota

Saint Lukes Hospital of Kansas City ( Site 0060), Kansas City, Missouri

New York Oncology Hematology P.C ( Site 8000), Albany, New York

Monter Cancer Center ( Site 0054), Lake Success, New York

Memorial Sloan Kettering Cancer Center-Rockerfeller Patient Pavilion ( Site 0049), New York, New York

White Plains Hospital Center for Cancer Care ( Site 0014), White Plains, New York

Providence Portland Medical Center ( Site 0097), Portland, Oregon

Kaiser Permanente Northwest ( Site 0037), Portland, Oregon

Parkland Health & Hospital System ( Site 2102), Dallas, Texas

University of Texas Southwestern Medical Center at Dallas ( Site 0035), Dallas, Texas

Utah Cancer Specialists ( Site 0001), Salt Lake City, Utah

Emily Couric Clinical Cancer Center ( Site 0020), Charlottesville, Virginia

Froedtert Hospital & the Medical College of Wisconsin ( Site 0041), Milwaukee, Wisconsin

Chris OBrien Lifehouse ( Site 0200), Camperdown, New South Wales

Westmead Hospital ( Site 0201), Westmead, New South Wales

Eastern Health ( Site 0202), Box Hill, Victoria

Austin Health ( Site 0203), Heidelberg, Victoria

Liga Norte Riograndense Contra o Cancer ( Site 1909), Natal, Rio Grande Do Norte

Hospital de Caridade de Ijui ( Site 1907), Ijui, Rio Grande Do Sul

Hospital Bruno Born ( Site 1913), Lajeado, Rio Grande Do Sul

Hospital de Clinicas de Porto Alegre ( Site 1905), Porto Alegre, Rio Grande Do Sul

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 1904), Porto Alegre, Rio Grande Do Sul

Fundacao Pio XII - Hospital de Cancer de Barretos ( Site 1911), Barretos, Sao Paulo

Hosp. Clinicas da Fac. de Medicina de Ribeirao Preto - USP ( Site 1912), Ribeirao Preto, Sao Paulo

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 1903), Sao Paulo, Not set

William Osler Health System ( Site 0100), Brampton, Ontario

Sunnybrook Health Sciences, Odette Cancer Centre ( Site 0102), Toronto, Ontario

Princess Margaret Cancer Centre ( Site 0104), Toronto, Ontario

Jewish General Hospital ( Site 0105), Montreal, Quebec

The First Affiliated Hospital of Anhui Medical University ( Site 0721), Hefei, Anhui

Cancer Hospital Chinese Academy of Medical Sciences ( Site 0717), Beijing, Beijing

Peking Union Medical College Hospital ( Site 0703), Beijing, Beijing

Beijing Cancer Hospital ( Site 0718), Beijing, Beijing

Southwest Hospital, The Third Military Medical University ( Site 0725), Chongqing, Chongqing

Fujian Cancer Hospital ( Site 0723), Fuzhou, Fujian

The Affiliated Tumour Hospital of Harbin Medical University ( Site 0706), Harbin, Heilongjiang

Henan Cancer Hospital ( Site 0711), Zhengzhou, Henan

Xiangya Hospital of Central South University ( Site 0710), Changsha, Hunan

Hunan Cancer Hospital ( Site 0722), Changsha, Hunan

Jiangsu Cancer Hospital ( Site 0719), Nanjing, Jiangsu

The First Hospital of Jilin University ( Site 0702), Chang chun, Jilin

Jilin Cancer Hospital ( Site 0705), Changchun, Jilin

Shanghai Chest Hospital ( Site 0700), Shanghai, Shanghai

Zhongshan Hospital Fudan University ( Site 0712), Shanghai, Shanghai

Tangdu Hospital ( Site 0708), XI An, Shanxi

The First Affiliated Hospital of Xi an Jiaotong University ( Site 0709), XI An, Shanxi

Affiliated Tumor Hospital of Xinjiang Medical University ( Site 0701), Urumqi, Xinjiang

The First Affiliated Hospital.Zhejiang University ( Site 0713), Hangzhou, Zhejiang

Sir Run Run Shaw Hospital School of Medicine, Zhejiang University ( Site 0715), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 0716), Hangzhou, Zhejiang

Centre Leon Berard ( Site 0801), Lyon, Auvergne

CHU Caen Service de Pneumologie ( Site 0804), Caen, Calvados

Centre Georges Francois Leclerc ( Site 0809), Dijon, Cote-d'Or

Hopital Jean Minjoz Besancon ( Site 0805), Besancon, Doubs

Hopital Prive d'Antony ( Site 0811), Antony, Hauts-de-Seine

C.H.U. de Tours - Hopital Bretonneau ( Site 0806), Tours, Indre-et-Loire

Centre D Oncologie de Gentilly ( Site 0810), Nancy, Meurthe-et-Moselle

Clinique Victor Hugo ( Site 0802), Le Mans, Sarthe

CHU Poitiers ( Site 0803), Poitiers, Vienne

Robert Bosch Krankenhaus Klinik Schillerhoehe ( Site 0904), Gerlingen, Baden-Wurttemberg

Universitaetsklinikum Mannheim ( Site 0911), Mannheim, Baden-Wurttemberg

Klinikum Wuerzburg Mitte gGmbH ( Site 0901), Wuerzburg, Bayern

Pius Hospital Oldenburg ( Site 0905), Oldenburg, Niedersachsen

Florence Nightingale Krankenhaus ( Site 0912), Duesseldorf, Nordrhein-Westfalen

Kliniken Essen-Mitte ( Site 0900), Essen, Nordrhein-Westfalen

Universitaetsklinikum Muenster ( Site 0906), Muenster, Nordrhein-Westfalen

Medizinische Fakultaet Carl Gustav Carus der TU Dresden ( Site 0907), Dresden, Sachsen

Asklepios Klinikum Hamburg ( Site 0908), Hamburg, Not set

Hong Kong Integrated Oncology Centre ( Site 0304), Hong Kong, Not set

Queen Mary Hospital ( Site 0301), Hong Kong, Not set

Queen Mary Hospital ( Site 0303), Hong Kong, Not set

Hong Kong United Oncology Centre ( Site 0306), Kowloon, Not set

Tuen Mun Hospital ( Site 0305), Tuen Mun, Not set

Barzilai Medical Center ( Site 1706), Ashkelon, HaDarom

Soroka Medical Center ( Site 1702), Beer-Sheva, HaDarom

Meir Medical Center ( Site 1701), Kfar-Saba, HaMerkaz

Rabin Medical Center ( Site 1704), Petah Tikva, HaMerkaz

Ha Emek Medical Center ( Site 1707), Afula, HaTsafon

Rambam Medical Center ( Site 1703), Haifa, Heifa

Chaim Sheba Medical Center. ( Site 1700), Ramat Gan, Tell Abib

Sourasky Medical Center ( Site 1705), Tel Aviv, Tell Abib

Istituto Europeo di Oncologia ( Site 1303), Milano, Lombardia

Ospedale San Vincenzo di Taormina ( Site 1302), Taormina, Messina

AOU San Luigi Gonzaga di Orbassano ( Site 1300), Orbassano, Torino

IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 1305), Bari, Not set

Azienda Ospedaliero Universitaria Careggi ( Site 1301), Firenze, Not set

Azienda Ospedaliera dei Colli V. Monaldi ( Site 1306), Napoli, Not set

Universita Campus Bio-Medico di Roma ( Site 1304), Roma, Not set

National Hospital Organization Nagoya Medical Center ( Site 0608), Nagoya, Aichi

Aichi Cancer Center Hospital ( Site 0612), Nagoya, Aichi

Fujita Health University Hospital ( Site 0619), Toyoake, Aichi

National Cancer Center Hospital East ( Site 0601), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 0616), Matsuyama, Ehime

Hyogo Cancer Center ( Site 0604), Akashi, Hyogo

Kanazawa University Hospital ( Site 0617), Kanazawa, Ishikawa

Kanagawa Cancer Center ( Site 0609), Yokohama, Kanagawa

Kansai Medical University Hospital ( Site 0606), Hirakata, Osaka

Shizuoka Cancer Center Hospital and Research Institute ( Site 0602), Sunto-gun, Shizuoka

National Hospital Organization Kyushu Medical Center ( Site 0621), Fukuoka, Not set

Kyushu University Hospital ( Site 0605), Fukuoka, Not set

Niigata Cancer Center Hospital ( Site 0610), Niigata, Not set

Okayama University Hospital ( Site 0614), Okayama, Not set

Osaka International Cancer Institute ( Site 0611), Osaka, Not set

National Cancer Center Hospital ( Site 0603), Tokyo, Not set

Toranomon Hospital ( Site 0615), Tokyo, Not set

Tokyo Metropolitan Komagome Hospital ( Site 0618), Tokyo, Not set

Wakayama Medical University Hospital ( Site 0613), Wakayama, Not set

Chungbuk National University Hospital ( Site 0404), Cheongju si, Chungcheongbuk-do [Chungbuk]

Gachon University Gil Medical Center ( Site 0408), Incheon, Incheon-gwangyeoksi [Incheon]

National Cancer Center ( Site 0400), Gyeonggi-do, Kyonggi-do

Seoul National University Bundang Hospital ( Site 0405), Seongnam-si, Kyonggi-do

Seoul National University Hospital ( Site 0402), Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center ( Site 0407), Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center ( Site 0403), Seoul, Seoul-teukbyeolsi [Seoul]

The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 0406), Seoul, Seoul-teukbyeolsi [Seoul]

Ulsan University Hospital ( Site 0401), Ulsan, Ulsan-Kwangyokshi

Instituto Jaliscience de Cancerologia ( Site 2000), Guadalajara, Jalisco

Medica Sur S.A.B de C.V. ( Site 2003), Mexico City, Not set

Oaxaca Site Management Organization SC ( Site 2001), Oaxaca, Not set

Instituto Nacional de Cancerologia. ( Site 2007), Tlalpan, Not set

Hospitalo Univ. Germans Trias i Pujol ( Site 1100), Badalona, Barcelona [Barcelona]

Hospital de la Santa Creu i Sant Pau ( Site 1102), Barcelona, Barcelona [Barcelona]

Hospital Universitari Vall d Hebron ( Site 1106), Barcelona, Barcelona [Barcelona]

Hospital Ramon y Cajal ( Site 1101), Madrid, Not set

Hospital Universitario 12 de Octubre ( Site 1103), Madrid, Not set

Complejo Hospitalario Carlos Haya de Malaga ( Site 1107), Malaga, Not set

Hospital Universitario Virgen Macarena ( Site 1104), Sevilla, Not set

Linkopings Universitetssjukhus ( Site 1504), Linkoping, Ostergotlands Lan [se-05]

Skanes Universitetssjukhus Lund ( Site 1503), Lund, Skane Lan [se-12]

Karolinska Universitetssjukhuset Solna ( Site 1500), Solna, Stockholms Lan [se-01]

Sahlgrenska Universitetssjukhuset ( Site 1502), Goteborg, Vastra Gotalands Lan [se-14]

Taipei Tzu Chi Hospital ( Site 0512), New Taipei City, New Taipei

Changhua Christian Hospital ( Site 0509), Changhua, Not set

National Taiwan University Hospital Hsin-Chu Branch ( Site 0511), Hsinchu, Not set

Hualien Tzu Chi Medical Center-Hospital ( Site 0510), Hualien, Not set

Kaohsiung Chang Gung Memorial Hospital ( Site 0507), Kaohsiung, Not set

Taipei Medical University Shuang Ho Hospital ( Site 0508), New Taipei, Not set

China Medical University Hospital ( Site 0505), Taichung, Not set

Taichung Veterans General Hospital ( Site 0504), Taichung, Not set

National Cheng Kung University Hospital ( Site 0506), Tainan, Not set

National Taiwan University Hospital ( Site 0500), Taipei, Not set

Mackay Memorial Hospital ( Site 0503), Taipei, Not set

Taipei Veterans General Hospital ( Site 0501), Taipei, Not set

Chang Gung Medical Foundation. Linkou ( Site 0502), Taoyuan, Not set

Sussex University Hospitals ( Site 1003), Brighton, Brighton And Hove

Western General Hospital ( Site 1009), Edinburgh, Edinburgh, City Of

Leicester Royal Infirmary ( Site 1000), Leicester, Leicestershire

University College London Hospitals NHS Foundation Trust ( Site 1006), London, London, City Of

Chelsea & Westminster Hospital ( Site 1001), London, London, City Of

Birmingham Heartlands Hospital ( Site 1002), Birmingham, Not set

St James s University Hospital ( Site 1008), Leeds, Not set

Barking Havering and Redbridge University Hospitals NHS Trust Queen s Hospital ( Site 1004), Romford, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

NCT05991388

Recruiting

The Glo-BNHL trial is trying to find better medicines for children and young people with B-cell non-Hodgkin Lymphoma (B-NHL) that does not go away (refractory B-NHL) or does but comes back again (relapsed B-NHL). B-NHL is a type of cancer that develops inside or outside of lymph nodes (glands) and organs such as the liver or spleen. Examples of B-NHL are Burkitt Lymphoma and Diffuse Large B Cell Lymphoma, which may be other names used to describe this type of cancer. It is very difficult to cure... Read More

Gender:

ALL

Ages:

25 years and below

Trial Updated:

11/05/2024

Locations: Birmingham Children's Hospital, Birmingham, Not set +2 locations

Conditions: B-cell Non Hodgkin Lymphoma

Learn More ›